Prospective randomized trial of hexylaminolevulinate photodynamic‐assisted transurethral resection of bladder tumour ( <scp>TURBT</scp> ) plus single‐shot intravesical mitomycin <scp>C</scp> vs conventional white‐light <scp>TURBT</scp> plus mitomycin <scp>C</scp> in newly presenting non‐muscle‐invasive bladder cancer

Abstract

Despite HAL-PDD offering a more accurate diagnostic assessment of a bladder tumour, in this trial we did not show that this led to lower recurrence rates of newly presenting NMIBC compared with the best current standard of care.